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Nanotechnology, nanomedicine and nanosurgeryAn exciting revolution in health care and med-
ical technology looms large on the horizon. Yet the
agents of change will be microscopically small,
future products of a new discipline known as
nanotechnology. Nanotechnology is the engineer-
ing of molecularly precise structures e typically
0.1 mm or smaller e and, ultimately, molecular
machines.
Nanomedicine1e4 is the application of nano-
technology to medicine. It is the preservation
and improvement of human health, using molecu-
lar tools and molecular knowledge of the human
body. Present-day nanomedicine exploits carefully
structured nanoparticles such as dendrimers,5 car-
bon fullerenes (buckyballs)6 and nanoshells7 to
target specific tissues and organs. These nanopar-
ticles may serve as diagnostic and therapeutic an-
tiviral, antitumor or anticancer agents. But as this
technology matures in the years ahead, complex
nanodevices and even nanorobots will be fabri-
cated, first of biological materials but later using
more durable materials such as diamond to
achieve the most powerful results.
Early vision
Can it be that someday nanorobots will be able to
travel through the body searching out and clearing
up diseases, such as an arterial atheromatous
plaque?8 The first and most famous scientist to
voice this possibility was the late Nobel physicist
Richard P. Feynman. In his remarkably prescient
1959 talk ‘‘There’s Plenty of Room at the Bottom,’’
Feynman proposed employing machine tools to
make smaller machine tools, these are to be
used in turn to make still smaller machine tools,
and so on all the way down to the atomic level,
noting that this is ‘‘a development which I think
cannot be avoided.’’91743-9191/$ - see front matter ª 2005 Surgical Associates Ltd. P
doi:10.1016/j.ijsu.2005.10.007Feynman was clearly aware of the potential
medical applications of this new technology. He
offered the first known proposal for a nanorobotic
surgical procedure to cure heart disease: ‘‘A friend
of mine (Albert R. Hibbs) suggests a very interest-
ing possibility for relatively small machines. He
says that, although it is a very wild idea, it would
be interesting in surgery if you could swallow the
surgeon. You put the mechanical surgeon inside
the blood vessel and it goes into the heart and
looks around. (Of course the information has to be
fed out.) It finds out which valve is the faulty one
and takes a little knife and slices it out. .[Imag-
ine] that we can manufacture an object that
maneuvers at that level!. Other small machines
might be permanently incorporated in the body to
assist some inadequately functioning organ.’’9
Medical microrobotics
There are ongoing attempts to build microrobots
for in vivo medical use. In 2002, Ishiyama et al. at
Tohoku University developed tiny magnetically
driven spinning screws intended to swim along
veins and carry drugs to infected tissues or even to
burrow into tumors and kill them with heat.10 In
2003, the ‘‘MR-Sub’’ project of Martel’s group at
the NanoRobotics Laboratory of Ecole Polytechni-
que in Montreal tested using variable MRI magnetic
fields to generate forces on an untethered micro-
robot containing ferromagnetic particles, develop-
ing sufficient propulsive power to direct the small
device through the human body.11 Brad Nelson’s
team at the Swiss Federal Institute of Technology
in Zurich continued this approach. In 2005, they
reported the fabrication of a microscopic robot
small enough (w200 mm) to be injected into the
body through a syringe. They hope that this device
or its descendants might someday be used to de-
liver drugs or perform minimally invasive eyeublished by Elsevier Ltd. All rights reserved.
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fully maneuvered through a watery maze using ex-
ternal energy from magnetic fields, with different
frequencies that are able to vibrate different me-
chanical parts on the device to maintain selective
control of different functions. Gordon’s group at
the University of Manitoba has also proposed mag-
netically controlled ‘‘cytobots’’ and ‘‘karyobots’’
for performing wireless intracellular and intranu-
clear surgery.13
Manufacturing medical nanorobots
The greatest power of nanomedicine will emerge,
perhaps in the 2020s, when we can design and
construct complete artificial nanorobots using rigid
diamondoid nanometer-scale parts like molecular
gears (Fig. 1) and bearings.14 These nanorobots
will possess a full panoply of autonomous subsys-
tems including onboard sensors, motors, manipula-
tors, power supplies, and molecular computers.
But getting all these nanoscale components to
spontaneously self-assemble in the right sequence
will prove increasingly difficult as machine struc-
tures become more complex. Making complex
nanorobotic systems requires manufacturing
Figure 1 A molecular planetary gear is a mechanical
component that might be found inside a medical nanoro-
bot. The gear converts shaft power from one angular fre-
quency to another. The casing is a strained silicon shell
with predominantly sulfur termination, with each of
the nine planet gears attached to the planet carrier by
a carbonecarbon single bond. The planetary gear shown
here has not been built experimentally but has been
modeled computationally. Copyright 1995 Institute for
Molecular Manufacturing (IMM).techniques that can build a molecular structure
by what is called positional assembly. This will in-
volve picking and placing molecular parts one by
one, moving them along controlled trajectories
much like the robot arms that manufacture cars
on automobile assembly lines. The procedure is
then repeated over and over with all the different
parts until the final product, such as a medical
nanorobot, is fully assembled.
The positional assembly of diamondoid struc-
tures, some almost atom by atom, using molecular
feedstock has been examined theoretically14,15 via
computational models of diamond mechanosyn-
thesis (DMS). DMS is the controlled addition of car-
bon atoms to the growth surface of a diamond
crystal lattice in a vacuum-manufacturing environ-
ment. Covalent chemical bonds are formed one by
one as the result of positionally constrained me-
chanical forces applied at the tip of a scanning
probe microscope apparatus, following a pro-
grammed sequence. Mechanosynthesis using sili-
con atoms was first achieved experimentally in
2003.16 Carbon atoms should not be far behind.17
To be practical, molecular manufacturing must
also be able to assemble very large numbers of
medical nanorobots very quickly. Approaches un-
der consideration include using replicative
manufacturing systems or massively parallel fabri-
cation, employing large arrays of scanning probe
tips all building similar diamondoid product struc-
tures in unison.18
For example, simple mechanical ciliary arrays
consisting of 10,000 independentmicroactuators on
a 1-cm2 chip have been made at the Cornell Nation-
al Nanofabrication Laboratory for microscale parts
transport applications, and similarly at IBM for me-
chanical data storage applications.19 Active probe
arrays of 10,000 independently actuated micro-
scope tips have been developed by Mirkin’s group
at Northwestern University for dip-pen nanolithog-
raphy20 using DNA-based ‘‘ink’’. Almost any desired
2D shape can be drawn using 10 tips in concert. An-
other microcantilever array manufactured by Proti-
veris Corp. has millions of interdigitated cantilevers
on a single chip. Martel’s group has investigated
using fleets of independently mobile wireless in-
strumented microrobot manipulators called Nano-
Walkers to collectively form a nanofactory system
that might be used for positional manufacturing
operations.21 Zyvex Corp. (www.zyvex.com) of
Richardson, TX has a $25million, five-year, National
Institute of Standards and Technology (NIST) con-
tract to develop prototype microscale assemblers
using microelectromechanical systems. This re-
search may eventually lead to prototype nanoscale
assemblers using nanoelectromechanical systems.
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The ability to build complex diamondoid medical
nanorobots to molecular precision, and then to
build them cheaply enough in sufficiently large
numbers to be useful therapeutically, will revolu-
tionize the practice of medicine and surgery.1 The
first theoretical design study of a complete medi-
cal nanorobot ever published in a peer-reviewed
journal (in 1998) described a hypothetical artificial
mechanical red blood cell or ‘‘respirocyte’’ made
of 18 billion precisely arranged structural atoms.22
The respirocyte is a bloodborne spherical 1-mm di-
amondoid 1000-atmosphere pressure vessel with
reversible molecule-selective surface pumps pow-
ered by endogenous serum glucose. This nanorobot
would deliver 236 times more oxygen to body tis-
sues per unit volume than natural red cells and
would manage carbonic acidity, controlled by gas
concentration sensors and an onboard nanocom-
puter. A 5-cc therapeutic dose of 50% respirocyte
saline suspension containing 5 trillion nanorobots
could exactly replace the gas carrying capacity of
the patient’s entire 5.4 l of blood.
Nanorobotic artificial phagocytes called ‘‘micro-
bivores’’ (Fig. 2) could patrol the bloodstream,
seeking out and digesting unwanted pathogens in-
cluding bacteria, viruses, or fungi.23 Microbivores
would achieve complete clearance of even the
most severe septicemic infections in hours or
less. This is far better than the weeks or months
needed for antibiotic-assisted natural phagocytic
defenses. The nanorobots do not increase the risk
of sepsis or septic shock because the pathogens
are completely digested into harmless sugars, ami-
no acids and the like, which are the only effluents
from the nanorobot.
Figure 2 Nanorobotic artificial phagocytes called ‘‘mi-
crobivores’’ could patrol the bloodstream, seeking out
and digesting unwanted pathogens. Copyright 2001
Zyvex Corp.; designer Robert Freitas, artist Forrest Bishop.Surgical nanorobotics
Surgical nanorobots could be introduced into the
body through the vascular system or at the ends of
catheters into various vessels and other cavities in
the human body. A surgical nanorobot, pro-
grammed or guided by a human surgeon, could
act as a semi-autonomous on-site surgeon inside
the human body. Such a device could perform
various functions such as searching for pathology
and then diagnosing and correcting lesions by
nanomanipulation, coordinated by an onboard
computer while maintaining contact with the
supervising surgeon via coded ultrasound signals.
The earliest forms of cellular nanosurgery are
already being explored today. For example, a rap-
idly vibrating (100 Hz) micropipette with a <1-mm
tip diameter has been used to completely cut den-
drites from single neurons without damaging cell
viability.24 Axotomy of roundworm neurons was
performed by femtosecond laser surgery, after
which the axons functionally regenerated.25 A
femtolaser acts like a pair of ‘‘nano-scissors’’ by
vaporizing tissue locally while leaving adjacent tis-
sue unharmed. Femtolaser surgery has performed
the followings: (1) localized nanosurgical ablation
of focal adhesions adjoining live mammalian epi-
thelial cells,26 (2) microtubule dissection inside
yeast cells,27 (3) noninvasive intratissue nanodis-
section of plant cell walls and selective destruc-
tion of intracellular single plastids or selected
parts of them,28 and even (4) the nanosurgery of
individual chromosomes (selectively knocking out
genomic nanometer-sized regions within the nu-
cleus of living Chinese hamster ovary cells29).
These procedures do not kill the cells upon which
the nanosurgery was performed. Atomic force mi-
croscopes have also been used for bacterium cell
wall dissection in situ in aqueous solution, with
26 nm thick twisted strands revealed inside the
cell wall after mechanically peeling back large
patches of the outer cell wall.30
Future nanorobots equipped with operating
instruments and mobility will be able to perform
precise and refined intracellular surgeries which
are beyond the capabilities of direct manipulation
by the human hand. We envision biocompatible31
surgical nanorobots that can find and eliminate
isolated cancerous cells, remove microvascular
obstructions and recondition vascular endothelial
cells, perform ‘‘noninvasive’’ tissue and organ
transplants, conduct molecular repairs on trauma-
tized extracellular and intracellular structures,
and even exchange new whole chromosomes for
old ones inside individual living human cells.
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